Press Releases

Date	Title	Company
21-Nov-2023	Evolva enters into an agreement to sell its operations to Lallemand, securing the best possible outcome for the company and its stakeholders	Evolva Holding SA
21-Nov-2023	Global Precision Cancer Imaging Industry anticipated expansion could lead it to US$ 210.58 Billion by 2032 \| FMI	MARKITWIRED
21-Nov-2023	Global Canine Flu Therapeutics Industry suggests it will attain US$ 3.06 Billion by 2033, buoyed by a 4.1% CAGR \| FMI	MARKITWIRED
21-Nov-2023	Global Bleeding Control Kit Industry is expected to achieve US$ 5,833.5 Million by 2033, according to an FMI study	MARKITWIRED
21-Nov-2023	Global Custom Hearing Aids Industry is set to reach a valuation of US$ 18,861.5 Million by 2033, as per FMI’s report	MARKITWIRED
21-Nov-2023	Global Home Sleep Apnea Testing Industry is set for expansion, expecting a 14.4% CAGR, aiming to hit US$ 3.09 Billion by 2032 \| FMI	MARKITWIRED
21-Nov-2023	First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study	Society for Industrial and Applied Mathematics
21-Nov-2023	Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson's Disease Patients Worldwide in Japan	Newswire
20-Nov-2023	MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction	MorphoSys AG
20-Nov-2023	Ad hoc: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction	MorphoSys AG
20-Nov-2023	Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)	Astex Pharmaceuticals
20-Nov-2023	Landmark medicines deal to boost nation’s health, save NHS £14 billion, and support research investment	Landmark medicines
20-Nov-2023	Pistoia Alliance Sets Out Strategic Priorities to Accelerate Sustainability, Adoption of AI, and use of FAIR and Real-World Data in R&D	Pistoia Alliance
20-Nov-2023	“Inizio Launch Elevate” Set to Help Global Pharma Maximize Product Launch Potential	Inizio
20-Nov-2023	Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis	Chiesi Group
20-Nov-2023	Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis	Chiesi Group
20-Nov-2023	Hovione acquires ExtremoChem and its portfolio of proprietary sugars to support customers with stabilization and delivery of biopharmaceuticals	Hovione
20-Nov-2023	Global Wearable Blood Pressure Monitor Industry Surging to US$ 8 Billion by 2032, at a ranging CAGR from 15% to 16% \| FMI Analysis	MARKITWIRED
20-Nov-2023	Global Paediatric Influenza Treatment Industry Set to Surge to US$ 847.7 Million by 2032, at a CAGR of 3.5% \| FMI Analysis	MARKITWIRED
20-Nov-2023	Global Ocular Tuberculosis Therapeutics Industry Eyes a Remarkable US$753.2 Million Valuation by 2032, Driven by a 5.8% CAGR \| FMI Analysis	MARKITWIRED